Results 151 to 160 of about 2,604,224 (268)

WCN24-1980 Efficacy and safety of zibotentan in combination with dapagliflozin in patients with CKD according to baseline diabetes status and kidney function

Kidney International Reports
Hiddo Lambers Heerspink, Arihiro Kiyosue, David Wheeler, Min Lin, Emma Wijkmark, Glenn Carlson, Anne-Kristina Mercier, Magnus Astrand, Sebastian Ueckert, Peter J. Greasley, Phil Ambery   +10 more
doaj   +1 more source

An unyielding voice: illness and late style in Radwa Ashour's Athqal min Radwa (Heavier than Radwa). [PDF]

Philos Ethics Humanit Med
AbdelRahman F.
europepmc   +1 more source

RIPK4 function interferes with melanoma cell adhesion and metastasis

Molecular Oncology, EarlyView.
RIPK4 promotes melanoma growth and spread. RIPK4 levels increase as skin lesions progress to melanoma. CRISPR/Cas9‐mediated deletion of RIPK4 causes melanoma cells to form less compact spheroids, reduces their migratory and invasive abilities and limits tumour growth and dissemination in mouse models.
Norbert Wronski, Sławomir Lasota, Ewelina Madej, Anna A. Brożyna, Małgorzata Szczygieł, Agnieszka Harazin‐Lechowska, Jan Czerbniak, Janusz Rys, Jaroslaw Czyz, Agnieszka Wolnicka‐Glubisz   +9 more
wiley   +1 more source

Chemical and Oxygen Isotopic Composition of Roman and Late Antique Glass from Northern Greece [PDF]

, 2017
Alberta Silvestri, Elissavet Ḏotsika, A. Longinelli, Enricomaria Selmo, Sophia Doukata-Demertzi   +4 more
openalex   +1 more source

COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells

Molecular Oncology, EarlyView.
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos, Gilar Gorji‐bahri, Lejla Gradjan, Julia Zajac, Kacper Gil, Yvonne Thokozile Nduku, Anna M. Blom   +6 more
wiley   +1 more source

Impact of screening on late-stage breast cancer in the Netherlands: a population-based cohort study (2007-2016). [PDF]

Breast
Lin Y, Sidorenkov G, Wang J, Greuter MJW, Houssami N, Dorrius MD, Siesling S, de Munck L, de Bock GH.   +8 more
europepmc   +1 more source

Falkirk in the later nineteenth century : churchgoing, work and status in an industrial town [PDF]

, 2012
Deborah Guasp
openalex  

Effect of severe contralateral carotid stenosis or occlusion on early and late outcomes after carotid endarterectomy [PDF]

, 2019
Min‐Jae Jeong, Hyunwook Kwon, Min-Ju Kim, Youngjin Han, Tae‐Won Kwon, Yong‐Pil Cho   +5 more
openalex   +1 more source

Pre‐analytical optimization of cell‐free DNA and extracellular vesicle‐derived DNA for mutation detection in liquid biopsies

Molecular Oncology, EarlyView.
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen, Lucrezia De Santis, Bret M. Stephens, Vincent Bernard, Jörg C. Kalff, Lara Braun, Phillipp Leyendecker, Johannes Röttgen, Daniel Weissinger, Anirban Maitra, Paola A. Guerrero, Alexander Semaan   +11 more
wiley   +1 more source

Annual trends and risk factors of late presentation of HIV at 19 referral hospitals in Indonesia: findings from the INA-PROACTIVE cohort. [PDF]

Lancet Reg Health Southeast Asia
Arlinda D, Yunihastuti E, Indrati AR, Merati TP, Papot E, Cromer D, Diana A, Naysilla AM, Dewantara RD, Susanto NH, Lukman N, Adi Pranata IW, Kosasih H, Lokida D, Karyana M, Hartono TS, Rai Kosa IG, Theresia D, Savitri D, Nugroho DK, Eppy E, Susila Utama IM, Jamil KF, Toruan IL, Samosir NE, Katu S, Farhanah N, Wahyunie S, Rusli M, Swastika WA, Ignatius Wullur WA, Subronto YW, Liang CJ, Ridzon R, Chen RY, Neal AT, INA-PROACTIVE Study Group.   +36 more
europepmc   +1 more source